J&J developing coronavirus vaccine, at least nine other vaccines under development

Two more companies have announced that they are developing vaccines to protect against the 2019-nCoV outbreak that was first detected in Wuhan, China, bringing the total number of vaccine development programs to at least 10.

Johnson & Johnson (NYSE:JNJ) “has initiated efforts to develop multiple vaccine candidates against coronavirus and broadly collaborate with others to screen its library of antiviral therapies which may contribute to providing immediate relief to the current coronavirus outbreak,” Paul Stoffels, J&J vice chairman and CSO, said in a statement provided to BioCentury. ...